Moomoo AI 已提取核心信息
Bristol-Myers Squibb Company (BMY) has issued a warning to its stockholders regarding an unsolicited mini-tender offer by Tutanota LLC to purchase up to 500,000 shares of BMY's common stock at $55.00 per share. This offer represents less than 0.025% of the company's outstanding common stock as of February 6, 2024. On February 14, 2024, BMY released a press statement advising shareholders to reject the offer, which is below the current market price and subject to numerous conditions, including Tutanota obtaining financing. The company emphasized that the offer is not endorsed by BMY and recommended that stockholders who have already tendered shares withdraw them before the offer's expiration at 5:00 p.m. ET on February 23, 2024. BMY also highlighted the risks associated with mini-tender offers, which are for less than 5% of a company's shares and are not subject to the same SEC disclosure and procedural requirements as larger tender offers.
Bristol-Myers Squibb Company (BMY) has issued a warning to its stockholders regarding an unsolicited mini-tender offer by Tutanota LLC to purchase up to 500,000 shares of BMY's common stock at $55.00 per share. This offer represents less than 0.025% of the company's outstanding common stock as of February 6, 2024. On February 14, 2024, BMY released a press statement advising shareholders to reject the offer, which is below the current market price and subject to numerous conditions, including Tutanota obtaining financing. The company emphasized that the offer is not endorsed by BMY and recommended that stockholders who have already tendered shares withdraw them before the offer's expiration at 5:00 p.m. ET on February 23, 2024. BMY also highlighted the risks associated with mini-tender offers, which are for less than 5% of a company's shares and are not subject to the same SEC disclosure and procedural requirements as larger tender offers.
百时美施贵宝公司（BMY）已就Tutanota LLC主动提出的小型招标要约向其股东发出警告，该要约以每股55.00美元的价格购买BMY的多达50万股普通股。截至2024年2月6日，该报价占该公司已发行普通股的不到0.025％。2024年2月14日，BMY发布了一份新闻声明，建议股东拒绝该要约，该要约低于当前的市场价格，并受许多条件的约束，包括Tutanota获得融资。该公司强调该要约未得到BMY的认可，并建议已经投标股票的股东在要约于美国东部时间2024年2月23日下午 5:00 到期之前撤回股票。BMY还强调了与小型招标要约相关的风险，这些要约涉及不到公司5％的股份，并且不受与更大规模的要约相同的美国证券交易委员会披露和程序要求的约束。
百时美施贵宝公司（BMY）已就Tutanota LLC主动提出的小型招标要约向其股东发出警告，该要约以每股55.00美元的价格购买BMY的多达50万股普通股。截至2024年2月6日，该报价占该公司已发行普通股的不到0.025％。2024年2月14日，BMY发布了一份新闻声明，建议股东拒绝该要约，该要约低于当前的市场价格，并受许多条件的约束，包括Tutanota获得融资。该公司强调该要约未得到BMY的认可，并建议已经投标股票的股东在要约于美国东部时间2024年2月23日下午 5:00 到期之前撤回股票。BMY还强调了与小型招标要约相关的风险，这些要约涉及不到公司5％的股份，并且不受与更大规模的要约相同的美国证券交易委员会披露和程序要求的约束。
有用
没用